Ai-Leen Chan

Ai-Leen Chan

Auto-generated profile, based on publicly available information

Ai-Leen Chan

Tumor Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
HLHue M. La
Hue M. La
JMJuho-Antti Mäkelä
Juho-Antti Mäkelä
ACAi-Leen Chan
Ai-Leen Chan
FRFernando J. Rossello
Fernando J. Rossello
CNChristian Nefzger
Christian Nefzger
RHRobin M. Hobbs
Robin M. Hobbs
The role of stem cells in tissue maintenance is appreciated and hierarchical models of stem cell self-renewal and differentiation often proposed. Stem cell activity in the male germline is restricted to undifferentiated A-type spermatogonia (Aundiff); however, only a fraction of this population act as stem cells in undisturbed testis and Aundiff hierarchy remains contentious. Through newly developed compound reporter mice, here we define molecular signatures of self-renewing and differentiation-primed adult Aundiff fractions and dissect Aundiff heterogeneity by single-cell analysis. We uncover an unappreciated population within the self-renewing Aundiff fraction marked by expression of embryonic patterning genes and homeodomain transcription factor PDX1. Importantly, we find that PDX1 marks a population with potent stem cell capacity unique to mature, homeostatic testis and demonstrate dynamic interconversion between PDX1+ and PDX1− Aundiff states upon transplant and culture. We conclude that Aundiff exist in a series of dynamic cell states with distinct function and provide evidence that stability of such states is dictated by niche-derived cues.

1 September 2017 in Stem Cell Reports
Verified
Journal Article
Open access
ACAi-Leen Chan
Ai-Leen Chan
HLHue M. La
Hue M. La
JLJulien M.D. Legrand
Julien M.D. Legrand
JMJuho-Antti Mäkelä
Juho-Antti Mäkelä
MEMichael Eichenlaub
Michael Eichenlaub
RHRobin M. Hobbs
Robin M. Hobbs
Sustained spermatogenesis in adult males and fertility recovery following germ cell depletion are dependent on undifferentiated spermatogonia. We previously demonstrated a key role for the transcription factor SALL4 in spermatogonial differentiation. However, whether SALL4 has broader roles within spermatogonia remains unclear despite its ability to co-regulate genes with PLZF, a transcription factor required for undifferentiated cell maintenance. Through development of inducible knockout models, we show that short-term integrity of differentiating but not undifferentiated populations requires SALL4. However, SALL4 loss was associated with long-term functional decline of undifferentiated spermatogonia and disrupted stem cell-driven regeneration. Mechanistically, SALL4 associated with the NuRD co-repressor and repressed expression of the tumor suppressor genes Foxl1 and Dusp4. Aberrant Foxl1 activation inhibited undifferentiated cell growth and survival, while DUSP4 suppressed self-renewal pathways. We therefore uncover an essential role for SALL4 in maintenance of undifferentiated spermatogonial activity and identify regulatory pathways critical for germline stem cell function.

17 April 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DSDebottam Sinha
Debottam Sinha
MKMurugan Kalimutho
Murugan Kalimutho
JBJosephine Bowles
Josephine Bowles
ACAi-Leen Chan
Ai-Leen Chan
DMD. Jo Merriner
D. Jo Merriner
Kum Kum KhannaKum Kum Khanna
Kum Kum Khanna
Spermatogenesis is a dynamic process involving self‐renewal and differentiation of spermatogonial stem cells, meiosis, and ultimately, the differentiation of haploid spermatids into sperm. Centrosomal protein 55 kDa (CEP55) is necessary for somatic cell abscission during cytokinesis. It facilitates equal segregation of cytoplasmic contents between daughter cells by recruiting endosomal sorting complex required for transport machinery (ESCRT) at the midbody. In germ cells, CEP55, in partnership with testes expressed‐14 (TEX14) protein, has also been shown to be an integral component of intercellular bridge before meiosis. Various in vitro studies have demonstrated a role for CEP55 in multiple cancers and other diseases. However, its oncogenic potential in vivo remains elusive. To investigate, we generated ubiquitously overexpressing Cep55 transgenic (Cep55 Tg / Tg )mice aiming to characterize its oncogenic role in cancer. Unexpectedly, we found that Cep55 Tg/Tg male mice were sterile and had severe and progressive defects in spermatogenesis related to spermatogenic arrest and lack of spermatids in the testes. In this study, we characterized this male‐specific phenotype and showed that excessively high levels of Cep55 results in hyperactivation of PI3K/protein kinase B (Akt) signaling in testis. In line with this finding, we observed increased phosphorylation of forkhead box protein O1 (FoxO1), and suppression of its nuclear retention, along with the relative enrichment of promyelocytic leukemia zinc finger (PLZF)—positive cells. Independently, we observed that Cep55 amplification favored upregulation of ret ( Ret ) proto‐oncogene and glial‐derived neurotrophic factor family receptor a‐1 ( Gfra1 ). Consistent with these data, we observed selective down‐regulation of genes associated with germ cell differentiation in Cep55‐overexpressing testes at postnatal day 10, including early growth response‐4 ( Egr4) and spermatogenesis and oogenesis specific basic helix‐loop‐helix‐1 ( Sohlh1 ). Thus, Cep55 amplification leads to a shift toward the initial maintenance of undifferentiated spermatogonia and ultimately results in progressive germ cell loss. Collectively, our findings demonstrate that Cep55 overexpression causes change in germ cell proportions and manifests as a Sertoli cell only tubule phenotype, similar to that seen in many azoospermic men.—Sinha, D., Kalimutho, M., Bowles, J., Chan, A.‐L., Merriner, D. J., Bain, A. L., Simmons, J. L., Freire, R., Lopez, J. A., Hobbs, R. M., O'Bryan, M. K., Khanna, K. K. Cep55 overexpression causes male‐specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling. FASEB J. 32, 4984–4999 (2018). www.fasebj.org

15 September 2018 in Development
Verified
Journal Article
Closed access
PDF file
HLHue M. La
Hue M. La
ACAi-Leen Chan
Ai-Leen Chan
JLJulien M. D. Legrand
Julien M. D. Legrand
FRFernando J. Rossello
Fernando J. Rossello
CGChristina G. Gangemi
Christina G. Gangemi
RHRobin M. Hobbs
Robin M. Hobbs
Male fertility is dependent on spermatogonial stem cells (SSCs) that self-renew and produce differentiating germ cells. Growth factors produced within the testis are essential for SSC maintenance but intrinsic factors dictating SSC response to these stimuli poorly characterised. Here we studied the role of GILZ, a TSC22D family protein and spermatogenesis regulator, in spermatogonial function and signalling. While broadly expressed in the germline, GILZ was prominent in undifferentiated spermatogonia and Gilz deletion in adults resulted in exhaustion of the GFRα1+ SSC-containing population and germline degeneration. GILZ loss was associated with mTORC1 activation, suggesting enhanced growth factor signalling. Expression of deubiquitinase USP9X, an mTORC1 modulator required for spermatogenesis, was disrupted in Gilz mutants. Treatment with an mTOR inhibitor rescued GFRα1+ spermatogonial failure, indicating that GILZ-dependent mTORC1 inhibition is critical for SSC maintenance. Analysis of cultured undifferentiated spermatogonia lacking GILZ confirmed aberrant activation of ERK MAPK upstream mTORC1 plus USP9X downregulation and interaction of GILZ with TSC22D proteins. Our data indicate an essential role for GILZ-TSC22D complexes in ensuring appropriate response of undifferentiated spermatogonia to growth factors via distinct inputs to mTORC1.

19 September 2016 in Oncogene
Verified
Journal Article
Closed access
PDF file
PPP J Paul
P J Paul
DRD Raghu
D Raghu
ACA-L Chan
A-L Chan
TGT Gulati
T Gulati
LLL Lambeth
L Lambeth
Ygal HauptYgal Haupt
Ygal Haupt

14 July 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MMMariam Mansour
Mariam Mansour
SHSue Haupt
Sue Haupt
ACAi-Leen Chan
Ai-Leen Chan
NGNathan Godde
Nathan Godde
ARAlexandra Rizzitelli
Alexandra Rizzitelli
Ygal HauptYgal Haupt
Ygal Haupt
Metastatic disease is the major cause of breast cancer–related death and despite many advances, current therapies are rarely curative. Tumor cell migration and invasion require actin cytoskeletal reorganization to endow cells with capacity to disseminate and initiate the formation of secondary tumors. However, it is still unclear how these migratory cells colonize distant tissues to form macrometastases. The E6-associated protein, E6AP, acts both as an E3 ubiquitin-protein ligase and as a coactivator of steroid hormone receptors. We report that E6AP suppresses breast cancer invasiveness, colonization, and metastasis in mice, and in breast cancer patients, loss of E6AP associates with poor prognosis, particularly for basal breast cancer. E6AP regulates actin cytoskeletal remodeling via regulation of Rho GTPases, acting as a negative regulator of ECT2, a GEF required for activation of Rho GTPases. E6AP promotes ubiquitination and proteasomal degradation of ECT2 for which high expression predicts poor prognosis in breast cancer patients. We conclude that E6AP suppresses breast cancer metastasis by regulating actin cytoskeleton remodeling through the control of ECT2 and Rho GTPase activity. These findings establish E6AP as a novel suppressor of metastasis and provide a compelling rationale for inhibition of ECT2 as a therapeutic approach for patients with metastatic breast cancer. Cancer Res; 76(14); 4236–48. ©2016 AACR.